| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Johnson Regional Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Clarksville, AR. To find more information about Johnson Regional Medical Center, please visit www.jrmc.com
Diteba Research Laboratories is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Transitional Living and Community Support is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AndHealth is a digital health solution that combines behavioral and clinical care for migraine and autoimmune conditions. Their virtual Center of Excellence delivers a Migraine Reversal Program via mobile app to enable migraine reversal.